Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

Fluoxetine Tablets Recalled for Excessive N-Nitroso Fluoxetine Impurity

Agency Publication Date: June 2, 2025
Share:
Sign in to monitor this recall

Summary

Torrent Pharma Inc. is recalling 4,644 units of Fluoxetine (fluoxetine) Tablets, 20 mg, including 30-count bottles and 28-count unit-dose cartons. The recall was issued because tests found levels of N-Nitroso Fluoxetine, a nitrosamine impurity, that exceed the FDA's interim acceptable intake limit. Consumers are advised to consult their healthcare provider or pharmacist regarding their prescription and should not stop taking their medication without medical guidance.

Risk

N-Nitroso Fluoxetine is a nitrosamine impurity that may increase the risk of cancer if individuals are exposed to it above acceptable levels over a long period of time. No reports of injuries or adverse events have been linked to this recall.

What You Should Do

  1. This recall affects Fluoxetine Tablets, USP, 20 mg, sold in 30-count bottles (NDC 13668-473-30) and 28-count unit-dose cartons (NDC 13668-473-91) containing blisters labeled with NDC 13668-473-70.
  2. Check your medication packaging for lot number BDX6K001 with an expiration date of 06/30/2025.
  3. If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer for further instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-723-3332 for additional questions regarding this recall.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Fluoxetine Tablets, USP (30-count bottle)
Variants: 20 mg, Tablets, 30-count bottle
Lot Numbers:
BDX6K001 (Exp. 06/30/2025)
NDC:
13668-473-30

Rx only; Manufactured for: Torrent Pharma Inc.

Product: Fluoxetine Tablets, USP (28-count Carton)
Variants: 20 mg, Tablets, 28-count Carton (4x7 Unit-dose)
Lot Numbers:
BDX6K001 (Exp: 06/30/2025)
NDC:
13668-473-91
13668-473-70

NDC 13668-473-91 refers to the Carton; 13668-473-70 refers to the Blister.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 96983
Status: Active
Manufacturer: Torrent Pharma Inc.
Sold By: Retail Pharmacies
Manufactured In: India, United States
Units Affected: 2 products (3672 Bottles; 972 Cartons)
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.